Organization | Field Name | ID | Required |
---|---|---|---|
KCR | SEER SSF 1 (HPV Status) (SEERSSF1) | 30139 | Yes |
SEER | SEER SSF 1 | Yes |
Field length: 1
This item is for cases diagnosed 01/01/2018 and forward. This data item is reserved for human papilloma virus (HPV) status.
Description
SEER Site-specific Factor 1, effective 01/01/2018, is reserved for human papilloma virus (HPV) status. This
data item applies to the following sites.
Schema | IDs |
---|---|
Buccal Mucosa | C060, C061 |
Floor of Mouth | C040-C041, C048-C049 |
Gum | C030, C031, C039, C062 |
Hypopharynx | C129, C130-C132, C138-C139 |
Lip | C003-C005, C008, C009 |
Mouth Other | C058-C059, C068-C069 |
Oropharynx (p16-) | C019, C024, C051-C052, C090-C091, C098-C099, C100, C102-C104, C108-C109, C111 |
Oropharynx HPV-Mediated (p16+) | C019, C024, C051-C052, C090-C091, C098-C099, C100, C102-C104, C108-C109, C111 |
Palate Hard | C050 |
Tongue Anterior | C020-C023, C028-C029 |
There is evidence that human papilloma virus (HPV) plays a role in the pathogenesis of some cancers. HPV
testing may be performed for prognostic purposes; testing may also be performed on metastatic sites to aid in
determination of the primary site.
Code | Description |
---|---|
10 | HPV negative by p16 test |
11 | HPV positive by p16 test |
20 | HPV negative for viral DNA by ISH test |
21 | HPV positive for viral DNA by ISH test |
30 | HPV negative for viral DNA by PCR test |
31 | HPV positive for viral DNA by PCR test |
40 | HPV negative by ISH E6/E7 RNA test |
41 | HPV positive by ISH E6/E7 RNA test |
50 | HPV negative by RT-PCR E6/E7 RNA test |
51 | HPV positive by RT-PCR E6/E7 RNA test |
70 | HPV status reported in medical records as negative, but test type is unknown |
71 | HPV status reported in medical records as positive, but test type is unknown |
97 | Test done, results not in chart |
99 | Not documented in medical record HPV test not done, not assessed, or unknown if assessed |
Coding Instructions
1. Record the results of any HPV testing performed on pathological specimens including surgical
and cytological (from cell blocks) tissue from the primary tumor or a metastatic site, including
lymph nodes. Do not record the results of blood tests or serology.
2. There are several methods for determination of HPV status. The most frequently used test is
IHC for p16 expression which is a surrogate marker for HPV infection. Other tests (based on
ISH, PCR, RT-PCR technologies) detect the viral DNA or RNA.
3. HPV-type 16 refers to virus type and is different from p16 overexpression (p16+)
4. Codes 10-51 are hierarchical; use the highest code that applies (10 is highest, 51 is lowest)
5. For cases in the Oropharynx HPV-Mediated (p16+) schema
a. If an additional HPV test is done in addition to p16, code those test results in this data item
b. If no additional HPV test is done, code 11 in this data item (Schema Discriminator 2 coded to 2)
6. For cases in the Oropharynx (p16-) schema
a. If an additional HPV test is done in addition to p16, code those test results in this data item
b. If no additional HPV test is done
i. Code 10 in this data item if Schema Discriminator 2 is coded to 1
ii. Code 99 in this data item if Schema Discriminator 2 is coded to 9